Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Derdak · SciRah

Researcher profile · Semantic Scholar

J. Derdak

Share profile

J. Derdak — researcher profile on SciRah

h-index: 15
Works: 28
Citations: 792

Most-cited papers

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
Sabina Kaczanowska, Tara Murty, A. Alimadadi, Cristina F. Contreras +40 more
2023Cancer Cell107 citations
Semantic Scholar
Long-Term Safety and Efficacy of Selumetinib in Children with Neurofibromatosis Type 1 on a Phase 1/2 Trial for Inoperable Plexiform Neurofibromas.
A. Gross, E. Dombi, P. Wolters, A. Baldwin +15 more
2023Neuro-Oncology94 citations Open access
Semantic Scholar
Persistent psychological distress in long‐term survivors of pediatric sarcoma: the experience at a single institution
L. Wiener, H. Battles, Donna Bernstein, Lauren M. Long +3 more
2006Psycho-Oncology75 citations Open access
Semantic Scholar
Treatment late effects in long‐term survivors of pediatric sarcoma
P. Mansky, A. Arai, P. Stratton, Donna Bernstein +14 more
2007Pediatric Blood & Cancer71 citations
Semantic Scholar
18-Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) Evaluation of Nodular Lesions in Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas (PN) or Malignant Peripheral Nerve Sheath Tumors (MPNST)
H. Meany, E. Dombi, J. Reynolds, M. Whatley +7 more
2012Pediatric Blood & Cancer67 citations Open access
Semantic Scholar
Metabolic syndrome traits in long‐term survivors of pediatric sarcoma
K. Hoffman, J. Derdak, Donna Bernstein, J. Reynolds +6 more
2008Pediatric Blood & Cancer59 citations
Semantic Scholar
Abbreviated Title:
Melissa Amaya, T. Whitcomb, A. Baldwin, J. Derdak +8 more
201757 citations
Semantic Scholar
Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.
A. Nella, M. Lodish, E. Fox, F. Balis +6 more
2014Journal of Clinical Endocrinology and Metabolism46 citations Open access
Semantic Scholar
The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas.
Sadhana Jackson, E. Baker, A. Gross, P. Whitcomb +10 more
2020Neuro-Oncology Advances35 citations Open access
Semantic Scholar
Selumetinib in Children with Neurofibromatosis Type 1 and Asymptomatic Inoperable Plexiform Neurofibroma At Risk for Developing Tumor-Related Morbidity.
A. Gross, Brittany Glassberg, P. Wolters, E. Dombi +19 more
2022Neuro-Oncology25 citations Open access
Semantic Scholar
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I related Plexiform Neurofibromas
Lauren H. Boal, J. Glod, Melissa Spencer, M. Kasai +10 more
2020Clinical Cancer Research24 citations Open access
Semantic Scholar
A Phase II Trial of Vandetanib (ZD6474, Caprelsa®) in Children and Adults with Succinate Dehydrogenase Deficient Gastrointestinal Stromal Tumor
J. Glod, Fernanda I. Arnaldez, L. Wiener, Melissa Spencer +11 more
2019Clinical Cancer Research18 citations Open access
Semantic Scholar
Phase I trial of ganitumab plus dasatinib to cotarget the insulin-like growth factor 1 receptor and Src family kinase YES in rhabdomyosarcoma
S. Akshintala, R. Sundby, Donna Bernstein, J. Glod +18 more
2023Clinical Cancer Research17 citations Open access
Semantic Scholar
Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).
Geraldine O'Sullivan Coyne, A. Gross, E. Dombi, C. Tibery +14 more
202016 citations
Semantic Scholar
Cediranib Phase II Study in Children with Metastatic Alveolar Soft Part Sarcoma (ASPS).
Julia W Cohen, B. Widemann, J. Derdak, E. Dombi +8 more
2019Pediatric Blood & Cancer16 citations Open access
Semantic Scholar
Disease Detection Methodologies in Relapsed B-Cell Acute Lymphoblastic Leukemia: Opportunities for Improvement
Haneen Shalabi, Constance M. Yuan, A. Kulshreshtha, Alina Dulau-Florea +13 more
2020Pediatric Blood & Cancer13 citations Open access
Semantic Scholar
Unusual Sites of Extraskeletal Metastases of Ewing Sarcoma after Allogeneic Hematopoietic Stem Cell Transplantation
C. Capitini, J. Derdak, M. Hughes, C. Love +3 more
2009Journal of pediatric hematology/oncology12 citations Open access
Semantic Scholar
Phase I study of pexidartinib (PLX3397) in children with refractory leukemias and solid tumors including neurofibromatosis type I (NF1) related plexiform neurofibromas (PN).
Lauren Hittson, J. Glod, Melissa Amaya, J. Derdak +2 more
20179 citations
Semantic Scholar
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial.
A. Gross, Olivia H Reid, L. A. Baldwin, A. Cannon +10 more
2025JAMA dermatology7 citations
Semantic Scholar
Cediranib phase II study in children with metastatic alveolar soft part sarcoma (ASPS).
J. Glod, Julia W Cohen, B. Widemann, A. Goodwin +7 more
20186 citations
Semantic Scholar
A phase II trial of vandetanib (ZD6474) in children and adults with wild-type gastrointestinal stromal tumors.
J. Glod, Fernanda I. Arnaldez, L. Wiener, Melissa Amaya +7 more
20164 citations
Semantic Scholar
Atypical neurofibromas in neurofibromatosis 1 (NF1): Clinical, imaging and pathologic characteristics.
C. Higham, S. Bhaumik, E. Dombi, A. Baldwin +4 more
20164 citations
Semantic Scholar
Abstract PR07: Phase II Trial of the MEK 1/2 inhibitor selumetinib (AZD6344, ARRY-142886 hydrogen sulphate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN)
G. Coyne, A. Gross, E. Dombi, J. DeSanto +18 more
2019MAPK Pathways1 citations
Semantic Scholar
RARE-07. THE EFFECT OF SELUMETINIB ON SPINAL NEUROFIBROMAS IN PATIENTS WITH NF1
Sadhana Jackson, E. Baker, A. Gross, T. Whitcomb +6 more
2018Neuro-Oncology1 citations Open access
Semantic Scholar
Phase II trial of the MEK1/2 inhibitor selumetinib (AZD6244) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs).
Diana Bradford, P. Whitcomb, E. Dombi, Alice P. Chen +16 more
20161 citations
Semantic Scholar
Metabolic syndrome traits in long-term survivors of pediatric sarcoma at a single institution.
K. Hoffman, J. Derdak, Donna Bernstein, J. Reynolds +5 more
2006Journal of Clinical Oncology1 citations
Semantic Scholar
Abstract 805: Intra-tumoral pharmacodynamics of selumetinib in serial biopsies from patients with neurofibroma
William G Herrick, Geraldine O'Sullivan Coyne, A. Gross, E. Dombi +14 more
2020Clinical research0 citations
Semantic Scholar
Disease Detection Methodologies in Acute Lymphoblastic Leukemia (ALL): Opportunities for Improvement
Haneen Shalabi, Constance M. Yuan, A. Kulshreshtha, Alina Dulau-Florea +11 more
2019Biology of Blood and Marrow Transplantation0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Dombi×18
Invite
E. Dombi — researcher profile on SciRah
B. Widemann×17
Invite
B. Widemann — researcher profile on SciRah
J. Glod×9
Invite
J. Glod — researcher profile on SciRah
A. Gross×9
Invite
A. Gross — researcher profile on SciRah

×8

Invite

A. Baldwin — researcher profile on SciRah

S. Steinberg×8

Invite

S. Steinberg — researcher profile on SciRah

Alice P. Chen×7

Invite

Alice P. Chen — researcher profile on SciRah

A. Carbonell×6

Invite

A. Carbonell — researcher profile on SciRah

Invite

P. Wolters — researcher profile on SciRah

Invite

C. Mackall — researcher profile on SciRah

Staci Martin×5

Invite

Staci Martin — researcher profile on SciRah

Donna Bernstein×5

Invite

Donna Bernstein — researcher profile on SciRah